Cusabio
SKU:CSB-RA005983MA1HU
CRLF2 (Verekitug) Recombinant Monoclonal Antibody
CRLF2 (Verekitug) Recombinant Monoclonal Antibody
Couldn't load pickup availability
| Release Date | 2025-10-16 |
|---|---|
| Product Code | CSB-RA005983MA1HU |
| Short Name | CRLF2 (Verekitug) Recombinant Monoclonal Antibody |
| Antibody Type | Recombinant Antibody |
| List Price | $350/100ul, $210/50ul |
| Species Reactivity | Human, Macaca fascicularis |
| Tested Applications | ELISA, WB |
| Dilution | ELISA:1:5000-1:50000, WB:1:1000-1:5000 |
| Purification Method | Affinity chromatography |
| Buffer Formulation | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4. |
| Antigen | Recombinant Human CRLF2 protein |
| Antigen Species | Human |
| Uniprot ID | Q9HC73 |
| Target Name | CRLF2 |
| Clonality | Monoclonal |
| Clone ID | 10A4 |
| Host Species | Human |
| Isotype | IgG1 |
| Conjugation | Non-conjugated |
| Form | Liquid |
| Storage Condition | Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze. |
| TDS URL | https://www.cusabio.com/datasheet/12945780/ |
| Size | 100ul |
Image 1
The Binding Activity of Macaca fascicularis CRLF2 with Anti-CRLF2 recombinant antibody
Activity: Measured by its binding ability in a functional ELISA.Immobilized Macaca fascicularis CRLF2(CSB-MP5357MOVd7) at 2 μg/mL can bind Anti-CRLF2 recombinant antibody. The EC<sub>50</sub> is 2.079-2.450 ng/mL.
Image 2
The Binding Activity of Human CRLF2 with Anti-CRLF2 recombinant antibody
Activity: Measured by its binding ability in a functional ELISA.Immobilized Human CRLF2(CSB-MP005983HU-B) at 2 μg/mL on streptavidin coated plates can bind Anti-CRLF2 recombinant antibody. The EC<sub>50</sub> is 3.631-7.668 ng/mL.
Image 3
Western Blot
Positive WB detected in: Jurkat whole cell lysate(30µg), THP-1 whole cell lysate(30µg), A-431 whole cell lysate(30µg), SH-SY5Y whole cell lysate(30µg)
All lanes: CRLF2 antibody at 1:1000
Secondary
Goat polyclonal to human IgG at 1/40000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
Exposure time: 2min
Share
